GMED
Price
$74.19
Change
+$0.63 (+0.86%)
Updated
Sep 11 closing price
Capitalization
9.96B
59 days until earnings call
Intraday BUY SELL Signals
WRBY
Price
$24.71
Change
+$0.41 (+1.69%)
Updated
Sep 11 closing price
Capitalization
3.05B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs WRBY

GMED vs WRBY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GMED vs. WRBY commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Hold and WRBY is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($9.96B) has a higher market cap than WRBY($3.05B). WRBY has higher P/E ratio than GMED: WRBY (411.83) vs GMED (18.97). WRBY YTD gains are higher at: 13.401 vs. GMED (-15.027). GMED has higher annual earnings (EBITDA): 954M vs. WRBY (55M). GMED has more cash in the bank: 595M vs. WRBY (293M). GMED has less debt than WRBY: GMED (111M) vs WRBY (251M). GMED has higher revenues than WRBY: GMED (3.15B) vs WRBY (912M).
GMEDWRBYGMED / WRBY
Capitalization9.96B3.05B326%
EBITDA954M55M1,735%
Gain YTD-15.02713.401-112%
P/E Ratio18.97411.835%
Revenue3.15B912M345%
Total Cash595M293M203%
Total Debt111M251M44%
FUNDAMENTALS RATINGS
GMED: Fundamental Ratings
GMED
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
65
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMEDWRBY
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 25 days ago
63%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
77%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (GMED: $74.19 vs. WRBY: $24.71)
Brand notoriety: GMED and WRBY are both not notable
GMED represents the Medical/Nursing Services, while WRBY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GMED: 102% vs. WRBY: 80%
Market capitalization -- GMED: $9.96B vs. WRBY: $3.05B
GMED [@Medical/Nursing Services] is valued at $9.96B. WRBY’s [@Pharmaceuticals: Other] market capitalization is $3.05B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green while WRBY’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • WRBY’s FA Score: 0 green, 5 red.
According to our system of comparison, GMED is a better buy in the long-term than WRBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 5 TA indicator(s) are bullish while WRBY’s TA Score has 3 bullish TA indicator(s).

  • GMED’s TA Score: 5 bullish, 5 bearish.
  • WRBY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GMED is a better buy in the short-term than WRBY.

Price Growth

GMED (@Medical/Nursing Services) experienced а -5.24% price change this week, while WRBY (@Pharmaceuticals: Other) price change was +1.48% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

Reported Earning Dates

GMED is expected to report earnings on Nov 10, 2026.

WRBY is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
GMED
Daily Signal:
Gain/Loss:
WRBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CRTC40.670.46
+1.14%
Xtrackers US National Crtcl Techs ETF
XRP15.220.15
+1.00%
Bitwise XRP ETF
DECZ43.890.33
+0.75%
TrueShares Structured Outcome Dec ETF
BSCQ19.560.01
+0.05%
Invesco BulletShares 2026 Corp Bd ETF
OND33.45N/A
N/A
ProShares On-Demand ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with TMCI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+0.86%
TMCI - GMED
46%
Loosely correlated
+3.68%
TNDM - GMED
46%
Loosely correlated
-6.55%
MDT - GMED
44%
Loosely correlated
-0.72%
SYK - GMED
43%
Loosely correlated
+2.06%
ILMN - GMED
42%
Loosely correlated
+2.57%
More